Company intelligence / Profile preview

Gyros Protein Technologies

Uppsala, Uppsala, Sweden

Ownership: Private
Development stage: Commercial

Overview

Gyros Protein Technologies offers commercialized automated immunoassay systems (Gyrolab) and advanced peptide synthesizers (PurePep), supporting research, drug discovery, preclinical development, clinical development, and bioprocessing. Their solutions are trusted by leading pharmaceutical companies, CROs/CMOs, and academic labs worldwide to accelerate the development of safer biotherapeutics.

Modalities: PeptidesProteins
Industry: Drug Discovery Services

Partnerships

BiotageLuxembourg Bio Technologies

Beyond the preview

Go deeper on Gyros Protein Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gyros Protein Technologies.

Explore the full profile